Emerald Advisers, LLC Puma Biotechnology, Inc. Transaction History

Emerald Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$20.07 - $46.7 $4.9 Million - $11.4 Million	-244,008 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$41.2 - $59.85 $5.02 Million - $7.29 Million	-121,779 Reduced 33.29%	244,008 $11.2 Million
Q2 2018 Jul 31, 2018	SELL	$48.3 - $68.25 $292,359 - $413,117	-6,053 Reduced 1.63%	365,787 $21.6 Million
Q1 2018 Apr 26, 2018	SELL	$59.7 - $99.25 $1.84 Million - $3.06 Million	-30,828 Reduced 7.66%	371,840 $25.3 Million
Q4 2017 Feb 05, 2018	BUY	$93.85 - $132.45 $3.06 Million - $4.32 Million	32,633 Added 8.82%	402,668 $39.8 Million
Q3 2017 Oct 30, 2017	BUY	$72.0 - $119.75 $26.6 Million - $44.3 Million	370,035	370,035 $44.3 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.